You are here

eflornithine

Orbus’s combo misses primary endpoint in Phase III brain cancer trial

Clinical Trials Arena

Mon, 11/25/24 - 09:25 am

Orbus Therapeutics

clinical trials

FDA adcomm backs US WorldMeds’ potential high-risk pediatric neuroblastoma drug

Medical Marketing and Media

Thu, 10/5/23 - 11:33 am

pediatric neuroblastoma

clinical trials